S20-217 Eterna Enterprise: A Secure Platform for Designing Enhanced mRNA Vaccines Stanford researchers have developed a secured, invite-only version of their popular Eterna platform for designing mRNA vaccines. Rhiju Das Do soon Kim Jonathan Romano
S20-224 Algorithm for Maximizing mRNA Thermodynamic Stability Stanford researchers have developed a stochastic algorithm MC sampler for designing mRNAs showing improved translation in vitro. Hannah Wayment-Steele Rhiju Das
S20-258 Chemical Additive Reduces Cost of Manufacturing mRNA Stanford researchers have discovered that ribonucleoside vanadyl complexes can be used as an additive in transcription reactions resulting in ~2-fold increased yield. Eesha Sharma Ivan Zheludev
S19-310 Rational Design of Ultratight RNA Aptamers against Protein Targets Stanford researchers have developed a computational approach for designing RNA modules with ultratight and ultraspecific recognition of any protein. Rhiju Das Kalli Kappel Joseph Yesselman
S19-020 MARIA-Neural network for accurate prediction of HLA class II antigen presentation The presentation of antigens by Human Leukocyte Antigen (HLA) class II molecules is an essential component of adaptive immune responses. Arash Alizadeh Russ Altman Binbin Chen Karan Kathuria